CD8A and cancer: In contrast, higher titres of some tumour‐infiltrating immune cells, such as CD4+ helper T cells, CD8+ cytotoxic T cells, natural killer (NK) cells and dendritic cells are associated with more favourable treatment outcomes and improved prognosis due to their ability to attack and destroy cancer cells.20